All the news Showing 10 of 1,614 articles from: Hepatitis CGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources Rapid hepatitis C testing to be rolled out at dozens of sites nationwide Sydney Morning Herald / 20 September 2021 Testing COVID-19 patients for viral hepatitis does not detect numerous undiagnosed cases Keith Alcorn / 19 September 2021 Screening people admitted to hospital with COVID-19 for hepatitis C or hepatitis B does not lead to detection of a large number of undiagnosed infections and is likely to be of limited ... Ultra-short course treatment for hepatitis C: high failure rate but does not compromise second-line treatment Keith Alcorn / 13 September 2021 Ultra-short treatment courses tailored to a person's pre-treatment viral load deliver lower cure rates than 8-week treatment courses, but failure of ultra-short treatment does not prevent subsequent cure of hepatitis ... Can Hepatitis C Self-Testing Bring Us Closer to Eliminating the Virus? The BodyPro / 03 September 2021 Short stay in prison increases the risk of hepatitis C for people who use drugs Keith Alcorn / 03 September 2021 People who use drugs were over 50% more likely to acquire hepatitis C between 2004 and 2019 if they spent even a brief period in prison, a prospective study carried out in ... Japanese study shows benefits of treating hepatitis C early Keith Alcorn / 24 August 2021 Curing hepatitis C in people with mild fibrosis by the age of 50 reduces their risk of death to the same level as the rest of the population, Japanese researchers report in ... High hepatitis C cure rate in Thai study of community-based treatment Keith Alcorn / 09 August 2021 Community-based testing and treatment for HIV and hepatitis C achieved high hepatitis C cure rates in Thailand, results from the Thai C-FREE study show. Tanyapom Wansom presented results from the C-FREE cohort study of ... Recommendations and guidance on hepatitis C virus self-testing World Health Organization / 09 August 2021 Hepatitis C vaccine could be rolled out within five years, says Nobel Prize winner who discovered virus European Society of Clinical Microbiology and Infectious Diseases press release / 13 July 2021 Immunotherapy plus arterial infusion chemotherapy shows promise for advanced liver cancer Liz Highleyman / 12 July 2021 An experimental immune checkpoint inhibitor plus chemotherapy delivered directly into the hepatic artery in the liver led to good outcomes in people with locally advanced hepatocellular carcinoma (HCC), the most common type of ... ← Prev1...34567...162Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Transmission and prevention Diagnosis and monitoring Disease course and symptoms HCV and coinfections Living with HCV Treatment issues Side effects Therapies Liver transplants Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Social issues Conference news Email bulletin archive